MBX Biosciences Inc. – Filings and Transcripts

NASDAQ: MBX
Share price (6/2/26): $30.70
Market cap (6/2/26): $1.461 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Shelf registration

Prospectus supplement with pricing info

Addition of securities to prior initial registration

Ownership Filter

Bartram Richard

Bartram Richard

Azoulay Salomon

Azoulay Salomon

Bartram Richard

News Filter

Provides Obesity Portfolio Update Including Initial Phase 1 Data for MBX 4291 Supporting Potential for Once-Monthly Dosing

Reports First Quarter 2026 Financial Results and Corporate Highlights

Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights

Announces Successful End-Of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism

Material Definitive Agreement, Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Correspondence with the SEC